Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial by Balar, Arjun V, Dr, Galsky, Matthew D, MD, Rosenberg, Jonathan E, MD, Powles, Thomas, MD, Petrylak, Daniel P, MD, Bellmunt, Joaquim, MD, Loriot, Yohann, MD, Necchi, Andrea, MD, Hoffman-Censits, Jean, MD, Perez-Gracia, Jose Luis, MD, Dawson, Nancy A, MD, van der Heijden, Michiel S, MD, Dreicer, Robert, MD, Srinivas, Sandy, MD, Retz, Margitta M, MD, Joseph, Richard W, MD, Drakaki, Alexandra, MD, Vaishampayan, Ulka N, MD, Sridhar, Srikala S, MD, Quinn, David I, MD, Durán, Ignacio, MD, Shaffer, David R, MD, Eigl, Bernhard J, MD, Grivas, Petros D, MD, Yu, Evan Y, MD, Li, Shi, PhD, Kadel, Edward E, BS, Boyd, Zachary, MSc, Bourgon, Richard, PhD, Hegde, Priti S, PhD, Mariathasan, Sanjeev, PhD, Thåström, AnnChristine, PhD, Abidoye, Oyewale O, MD, Fine, Gregg D, MD, Bajorin, Dean F, MD

Get full text